Fadi Khreish

1.2k total citations
46 papers, 867 citations indexed

About

Fadi Khreish is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Fadi Khreish has authored 46 papers receiving a total of 867 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 37 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Oncology. Recurrent topics in Fadi Khreish's work include Radiopharmaceutical Chemistry and Applications (35 papers), Prostate Cancer Treatment and Research (33 papers) and Peptidase Inhibition and Analysis (17 papers). Fadi Khreish is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (35 papers), Prostate Cancer Treatment and Research (33 papers) and Peptidase Inhibition and Analysis (17 papers). Fadi Khreish collaborates with scholars based in Germany, Netherlands and Jordan. Fadi Khreish's co-authors include Samer Ezziddin, Florian Rosar, Mark Bartholomä, Stephan Maus, Johannes Linxweiler, Tobias Stemler, Martin Ries, Matthias Saar, Caroline Burgard and Andrea Schaefer-Schuler and has published in prestigious journals such as PLoS ONE, Scientific Reports and Theranostics.

In The Last Decade

Fadi Khreish

45 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fadi Khreish Germany	17	710	686	270	84	59	46	867
Florian Rosar Germany	21	823 1.2×	804 1.2×	290 1.1×	100 1.2×	65 1.1×	76	1.0k
Karina Knorr Germany	12	819 1.2×	851 1.2×	290 1.1×	103 1.2×	69 1.2×	29	1.0k
Martina Weineisen Germany	7	742 1.0×	754 1.1×	250 0.9×	52 0.6×	79 1.3×	12	942
Marcus Bronzel Germany	6	828 1.2×	683 1.0×	288 1.1×	45 0.5×	84 1.4×	12	940
Adam Hickey Australia	10	571 0.8×	712 1.0×	104 0.4×	104 1.2×	39 0.7×	13	810
Martina Wirtz Germany	8	535 0.8×	560 0.8×	207 0.8×	39 0.5×	58 1.0×	8	683
Seval Beykan Germany	9	627 0.9×	507 0.7×	327 1.2×	43 0.5×	54 0.9×	13	843
Stefan Kürpig Germany	15	1.2k 1.6×	1.0k 1.5×	461 1.7×	88 1.0×	97 1.6×	25	1.3k
Mark Scalzo Australia	7	1.1k 1.5×	1.1k 1.6×	398 1.5×	117 1.4×	110 1.9×	10	1.3k
Srinivasan Senthamizhchelvan United States	14	820 1.2×	581 0.8×	160 0.6×	113 1.3×	83 1.4×	26	1.1k

Countries citing papers authored by Fadi Khreish

Since Specialization

Citations

This map shows the geographic impact of Fadi Khreish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Khreish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Khreish more than expected).

Fields of papers citing papers by Fadi Khreish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi Khreish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Khreish. The network helps show where Fadi Khreish may publish in the future.

Co-authorship network of co-authors of Fadi Khreish

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Khreish. A scholar is included among the top collaborators of Fadi Khreish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Khreish. Fadi Khreish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burgard, Caroline, Fadi Khreish, Andrea Schaefer-Schuler, et al.. (2024). Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy. Cancers. 16(20). 3532–3532.

Rosar, Florian, Caroline Burgard, Robert J. Marlowe, et al.. (2024). Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific Reports. 14(1). 11271–11271. 6 indexed citations

Burgard, Caroline, Florian Rosar, Fadi Khreish, et al.. (2024). Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer. Cancer Imaging. 24(1). 132–132. 2 indexed citations

Rosar, Florian, Caroline Burgard, Fadi Khreish, et al.. (2024). [89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis. Cancer Imaging. 24(1). 27–27. 1 indexed citations

Rosar, Florian, Caroline Burgard, Mark Bartholomä, et al.. (2024). Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study). European Journal of Nuclear Medicine and Molecular Imaging. 51(13). 4151–4162. 6 indexed citations

Rosar, Florian, Fadi Khreish, Robert J. Marlowe, et al.. (2023). Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2899–2909. 13 indexed citations

Rosar, Florian, Stephan Maus, Andrea Schaefer-Schuler, et al.. (2023). New Horizons in Radioligand Therapy. Clinical Nuclear Medicine. 48(5). 433–434. 23 indexed citations

Rosar, Florian, et al.. (2022). Strongly Radioiodine-Positive Pancreatic Adenocarcinoma Mimicking Metastasis of Differentiated Thyroid Cancer. Diagnostics. 12(8). 1934–1934. 2 indexed citations

Sabet, Amir, Joerg Thomas Bittenbring, Fadi Khreish, et al.. (2021). Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE. Pharmaceuticals. 14(10). 1022–1022. 2 indexed citations

10.

Rosar, Florian, Jonas Krause, Mark Bartholomä, et al.. (2021). Efficacy and Safety of [225Ac]Ac-PSMA-617 Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Highly Advanced mCRPC with Poor Prognosis. Pharmaceutics. 13(5). 722–722. 44 indexed citations

11.

Rosar, Florian, Euy Sung Moon, Frank Rösch, et al.. (2021). Impact of prompt gamma emission of 44Sc on quantification in preclinical and clinical PET systems. Applied Radiation and Isotopes. 170. 109599–109599. 6 indexed citations

12.

Khreish, Fadi, Florian Rosar, Amir Sabet, et al.. (2020). Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing 177Lu-PSMA-617 radioligand therapy. European Journal of Nuclear Medicine and Molecular Imaging. 48(1). 103–112. 28 indexed citations

13.

Rosar, Florian, Martin Ries, Andrea Schaefer, et al.. (2020). New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade: Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 687–694. 43 indexed citations

14.

Maus, Stephan, Tobias Stemler, Florian Rosar, et al.. (2020). Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates. Molecular Imaging and Biology. 23(1). 95–108. 7 indexed citations

15.

Rosar, Florian, Martin Ries, Johannes Linxweiler, et al.. (2020). Neuron-specific enolase has potential value as a biomarker for [18F]FDG/[68Ga]Ga-PSMA-11 PET mismatch findings in advanced mCRPC patients. EJNMMI Research. 10(1). 52–52. 18 indexed citations

16.

Rosar, Florian, Martin Ries, Fadi Khreish, & Samer Ezziddin. (2019). Remember the Pitfall. Clinical Nuclear Medicine. 45(3). 250–251. 4 indexed citations

17.

Khreish, Fadi, Martin Ries, Stephan Maus, et al.. (2019). 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 721–728. 151 indexed citations

18.

Böhm, Michael, et al.. (2018). The first post-cardiac injury syndrome reported following transcatheter aortic valve implantation: a case report. European Heart Journal - Case Reports. 2(4). yty107–yty107. 10 indexed citations

19.

Fleckenstein, Jochen, Stephanie Kremp, Fadi Khreish, et al.. (2016). The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer. PLoS ONE. 11(9). e0162816–e0162816. 15 indexed citations

20.

Khreish, Fadi, et al.. (2011). Simultaneous Occurrence of Typical Carcinoid and Non–Small-Cell Lung Cancer in the Same Lung Lobe. Clinical Nuclear Medicine. 36(6). 481–483. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact